Product Information
CLONAZEPAM 0.5 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4994 per EA under NDC 00093929267. Its NADAC has been published 213 times since Jun 1, 2022.
Strength
.5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093929267
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077194On Market Since
3/2/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG ODT has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 39.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4994 per EA |
|---|---|
| All-time high | $0.8205 (Jun 15, 2022) |
| All-time low | $0.3899 (Jul 17, 2024) |
| 52-week high | $0.6045 |
| 52-week low | $0.4889 |
| Median price | $0.5360 |
| Average price | $0.5476 |
| Largest weekly change | +48.4% (Aug 21, 2024) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $0.4994 per EA (NDC 00093929267), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.5 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG ODT has declined 39.1%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG ODT?
Since Jun 1, 2022, the NADAC for CLONAZEPAM 0.5 MG ODT has ranged from a low of $0.3899 (Jul 17, 2024) to a high of $0.8205 (Jun 15, 2022), with a median of $0.5360 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG ODT?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CLONAZEPAM 0.5 MG TABLET, is $0.0199 per EA — about 96% below CLONAZEPAM 0.5 MG ODT.
Who manufactures CLONAZEPAM 0.5 MG ODT?
CLONAZEPAM 0.5 MG ODT (NDC 00093929267) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification